Cabozantinib Plus Telgaglenstat (CB-839): A Phase II Combination in Patients with Well-Differentiated Gastroenteropancreatic NETs Home ยป Cabozantinib Plus Telgaglenstat (CB-839): A Phase II Combination in Patients with Well-Differentiated Gastroenteropancreatic NETs Cabozantinib Plus Telgaglenstat (CB-839): A Phase II Combination in Patients with Well-Differentiated Gastroenteropancreatic NETs Das Download The Abstract Abstract Download The Poster Poster
